Remembering to take your VOYDEYA™

CAN BE AS EASY AS 1-2-3

  1. Sign up for our text-based reminder service.
  2. Select your three daily reminder times.
  3. Receive alerts when it’s time to take your medicine.

FRIDAY

8:00AM

Hello - It’s time to take the 8 am dose of your Alexion oral PNH Medication...

FRIDAY

8:00AM

Hello - It’s time to take the 8 am dose of your Alexion oral PNH Medication...

VOYDEYA Reminders SMS/MMS Terms and Conditions

By clicking "Submit" below, you are requesting to sign up for VOYDEYA Reminder SMS/MMS text messages.  You will receive a confirmation code message at the number entered above, to confirm that you have requested such reminders.  Text ‘HELP’ for technical questions. To stop receiving messages, you can reply "STOP" at any time to the reminder text messages.

There is no fee from Alexion Pharmaceuticals for the reminder text messages.  However, your mobile service provider may charge for receipt of text messages including VOYDEYA reminder messages.  You should obtain information about any such charges from your mobile service provider.  Such charges, if any, would likely be billed and payable to your mobile service provider or deducted from your prepaid account.

  1. Data obtained from you in connection with this SMS/MMS service may include your cell phone number, your carrier’s name, your time zone, and the times you submit at which you wish to receive reminder text messages. We will use this information to contact you and to provide the services you request from us.
  2. For information on data collection and use please read our full corporate Privacy Notice https://alexion.com/Legal#privacynotice.
  3. While the VOYDEYA Reminder text message service is intended to make it easier for patients to remember to take their medication at appropriate times, it is ultimately the responsibility of the patient to remember and to actually take VOYDEYA at the proper times. By agreeing to these Terms and Conditions, you agree that neither Alexion nor any mobile service provider will be liable for any failure in transmission, receipt, or usability of any VOYDEYA Reminder text messages, regardless of the nature, cause or frequency of such failed transmission, receipt, or usability.
  4. Alerts sent via SMS/MMS may not be delivered if the mobile phone is not in range of a transmission site, or if sufficient network capacity is not available at a particular time. Even within a coverage area, factors beyond the control of the wireless carrier may interfere with message delivery, including the customer’s equipment, terrain, proximity to buildings, foliage, and weather. You should be aware of the quality of mobile service available in a particular area when determining whether to rely on VOYDEYA Reminder text messages to take your medication. 
  5. The service is available on U.S. carriers.
  6. VOYDEYA reminder message frequency may vary depending on user input.  Users can unsubscribe from this service at any time by replying ‘STOP’ to any medication reminder texts.
  7. For technical questions, text ‘HELP’ to any medication reminder text.

PRIVACY NOTICE – VOYDEYA Reminder Text Messages

Drafted: August 2024

WHO HAS DEVELOPED THE VOYDEYA TEXT MESSAGE REMINDER PROGRAM

The VOYDEYA Reminder Text Message program (the “Text Reminder Program” or the “Program”) has been developed by Alexion AstraZeneca Rare Disease Unit, 121 Seaport Blvd Boston, MA 02210; (“we”, “us”, “our”).

PURPOSE OF THE TEXT REMINDER PROGRAM

The main purpose of the Text Reminder Program is to help patients manage their medication schedule. 

DATA THE PROGRAM COLLECTS, WHY IT IS COLLECTED AND WHAT IT IS USED FOR

In order to use the Program as intended, users will be asked to provide the following information about themselves and their medication usage:  Mobile phone number, time zone, and three reminder times, corresponding to the three times per day the user intends to take his or her VOYDEYA dosages.  Use of the Text Reminder Program is voluntary.

Alexion will not obtain any information through this service other than the information the user provides.  Aside from the mobile phone number, no information that can be used to identify you will be collected by Alexion or shared with us as a function of the program.

CATEGORIES OF ENTITIES WITH WHOM WE MAY DISCLOSE YOUR INFORMATION

We grant access to your information only to the extent needed to perform business functions and require entities that receive your information to protect the confidentiality and security of such information.

We will not share or sell your personal information to third parties except in the following circumstances:

  • We may disclose all of the information we collect in connection with a business transfer or sale, for example, as part of a sale, assignment, or transfer of a business or asset, or acquisition of or merger with another entity.  In the event of such a transfer, the acquiring entity would be limited in their use of the data we collect in the same manner set forth herein with respect to Alexion.
  • We also may disclose any of the information we collect in response to requests from government or law enforcement agencies or where required or permitted by applicable laws, court orders, or government regulations, for example, in response to a subpoena or regulatory inquiry.
  • We may disclose all of the information we collect to protect rights and interests, for example, when needed for corporate audits, to investigate or respond to a complaint or threat, or to exercise our legal rights.

STORAGE OF DATA

All the information supplied as a result of the Text Reminder Program will be stored by Alexion on secure servers in the United States.  This information may be transferred in accordance with any legal obligations as set forth above.  If you opt out of the Text Reminder Program at a future time, you are removed from future notifications and your phone number and reminder selections will be deleted.

SECURITY OF YOUR DATA

We endeavor to ensure your information is kept confidential and secure and its use is limited to the purposes specified herein.  We have implemented privacy and security controls designed to help protect your data. Please note, however, that no security measures are 100% effective, and we cannot guarantee absolute security of your data.

CONTACT DETAILS 

You may request access to the information held about you, to correct any mistakes or to request deletion of your information or withdraw your consent to certain types of processing of your information via email at privacy@alexion.com. If such a request places Alexion in breach of obligations under applicable laws, regulations or codes of practice, then we may be forced to decline your request, but you may still be able to request that your information is blocked for further processing. You may also have a right to data portability to another entity under certain circumstances.

UPDATES

We reserve the right to amend this Privacy Notice at our discretion and at any time.

IMPORTANT SAFETY
INFORMATION FOR VOYDEYA

IMPORTANT SAFETY INFORMATION

What is the most important information I should know about VOYDEYA?

VOYDEYA is a medicine that affects your immune system. VOYDEYA may lower the ability of your immune system to fight infections.

  • VOYDEYA increases your chance of getting serious infections caused by encapsulated bacteria. These serious infections may quickly become life-threatening and cause death if not recognized and treated early.
  1. You must complete or update meningococcal vaccine(s) and streptococcus vaccine(s) at least 2 weeks before your first dose of VOYDEYA.
  2. If you have not completed your vaccinations and VOYDEYA must be started right away, you should receive the required vaccinations as soon as possible.
  3. If you have not been vaccinated at least 2 weeks before your first VOYDEYA dose and VOYDEYA must be started right away, you should also receive antibiotics to take for as long as your healthcare provider tells you.
  4. If you have been vaccinated against these bacteria in the past, you might need additional vaccinations before starting VOYDEYA. Your healthcare provider will decide if you need additional vaccinations.
  5. Vaccines do not prevent all infections caused by encapsulated bacteria. Call your healthcare provider or get emergency medical care right away if you have any of these signs and symptoms of a serious infection: fever with or without chills, fever and a rash, fever with chest pain and cough, fever with breathlessness/fast breathing, fever with high heart rate, headache with nausea or vomiting, headache and a fever, headache with a stiff neck or stiff back, confusion, body aches with flu-like symptoms, clammy skin, eyes sensitive to light.

Your healthcare provider will give you a Patient Safety Card about the risk of serious infections. Carry it with you at all times during treatment and for 1 week after your last VOYDEYA dose. Your risk of serious infections may continue for a few days after your last dose of VOYDEYA. It is important to show this card to any healthcare provider who treats you. This will help them diagnose and treat you quickly.

VOYDEYA is only available through a program called the VOYDEYA Risk Evaluation and Mitigation Strategy (REMS). Before you can take VOYDEYA, your healthcare provider must: enroll in the VOYDEYA REMS; counsel you about the risk of serious infections caused by certain bacteria; give you information about the symptoms of serious infections; make sure that you are vaccinated against serious infections caused by encapsulated bacteria and that you receive antibiotics if you need to start VOYDEYA right away and you are not up to date on your vaccinations; give you a Patient Safety Card about your risk of serious infections, as discussed above.

Who should not receive VOYDEYA?

Do not take VOYDEYA if you have a serious infection caused by encapsulated bacteria, including Neisseria meningitidis, Streptococcus pneumoniae, or Haemophilus influenzae type B infection.

Before taking VOYDEYA, tell your healthcare provider about all of your medical conditions, including if you: have an infection or fever, have liver problems, are pregnant or plan to become pregnant, or are breastfeeding. It is not known if VOYDEYA will harm your unborn baby or if it passes into your breast milk. Do not breastfeed during treatment with VOYDEYA and for 3 days after the last dose.

Tell your healthcare provider about all the vaccines you receive and medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements which could affect your treatment. VOYDEYA may affect the way other medicines work.

If you stop taking VOYDEYA, your healthcare provider will need to monitor you closely for at least 2 weeks after your last dose. Stopping treatment with VOYDEYA may cause a breakdown of red blood cells due to PNH. Symptoms or problems that can happen due to breakdown of red blood cells include: decreased hemoglobin level in your blood and tiredness

What are the possible side effects of VOYDEYA?

VOYDEYA can cause serious side effects, including increased liver enzyme levels and increased cholesterol. Your healthcare provider will do blood tests to check your liver enzyme levels and cholesterol before and during treatment with VOYDEYA. Your healthcare provider may temporarily or permanently stop treatment with VOYDEYA if you develop increased liver enzyme levels.

The most common side effect of VOYDEYA is headache.

Tell your healthcare provider about any side effect that bothers you or that does not go away. These are not all of the possible side effects of VOYDEYA. For more information, ask your healthcare provider or pharmacist. Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

INDICATION

What is VOYDEYA?

VOYDEYA is a prescription medicine used along with ravulizumab or eculizumab to treat breakdown of red blood cells that takes place outside of blood vessels (extravascular hemolysis), in adults with paroxysmal nocturnal hemoglobinuria (PNH).

It is not known if VOYDEYA is safe and effective in children.

Please see the full Prescribing Information and Medication Guide for VOYDEYA (danicopan), including Boxed WARNING regarding serious infections caused by encapsulated bacteria.